William Blair Reiterates Outperform Rating on Harrow Health (HROW): "We believe the long-term growth outlook is attractive"
Tweet Send to a Friend
William Blair analyst Lachlan Hanbury-Brown reiterated an Outperform rating on Harrow Health (NASDAQ: HROW)The analyst commented, "We believe Harrow is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
